What is a cryptogenic stroke?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is a Cryptogenic Stroke?

A cryptogenic stroke is an ischemic stroke for which no probable cause can be identified despite completing a thorough diagnostic evaluation that includes standard brain imaging, vascular imaging, cardiac screening, and laboratory testing. 1, 2

Core Definition

  • Cryptogenic stroke represents approximately one-fifth to one-third of all ischemic strokes, making it a commonly encountered clinical problem 2, 3, 4
  • The diagnosis is made through systematic exclusion after ruling out the four major stroke subtypes: large/medium artery atherosclerosis with stenosis, cardioembolic sources, lacunar stroke from small vessel disease, and other specific identified conditions 2
  • No existing guideline specifies the minimum investigations required before classifying a stroke as cryptogenic, creating inevitable practice variability across institutions 1

Required Standard Workup Before Diagnosis

Before labeling a stroke as cryptogenic, the following investigations must be completed:

Neuroimaging

  • Brain imaging (CT or MRI) to confirm ischemic stroke and exclude hemorrhage 1

Vascular Assessment

  • Non-invasive vascular imaging (CTA, MRA, or carotid ultrasound) to evaluate for large-vessel atherosclerosis and arterial dissection 1

Cardiac Evaluation

  • 12-lead ECG for all patients to screen for atrial fibrillation and arrhythmias 1
  • Cardiac monitoring exceeding 24 hours is recommended when an embolic mechanism is suspected, as single 24-hour Holter monitoring frequently misses paroxysmal atrial fibrillation 1
  • Transthoracic echocardiography when clinical features suggest a cardiac source 1

Laboratory Testing

  • Routine blood work including complete blood count, metabolic panel, lipid profile, and glucose 1

Clinical Subclassification: ESUS

  • Embolic Stroke of Undetermined Source (ESUS) is a more refined subgroup within cryptogenic stroke that specifically refers to non-lacunar cryptogenic strokes where embolism is the suspected mechanism 2, 3
  • This classification was introduced to create a more homogeneous population for research and treatment trials 2

Heterogeneity and Hidden Causes

Cryptogenic stroke remains a highly heterogeneous entity with multiple potential underlying mechanisms, including:

  • Paroxysmal atrial fibrillation (though less common than initially expected) 5, 6
  • Non-stenotic atherosclerosis and its risk factors are actually common in these patients 2
  • Intracranial and extracranial atherosclerosis 5
  • Atrial cardiopathy 7
  • Patent foramen ovale 7
  • Occult malignancy, heart failure, and infections 7

Critical Pitfall to Avoid

The most common mistake is inadequate cardiac monitoring. A single 24-hour Holter monitor misses a substantial proportion of paroxysmal atrial fibrillation; extended monitoring (weeks to months) or implantable loop recorders detect silent atrial fibrillation in up to 43% of cryptogenic stroke patients compared to only 7% with standard care 6. Early implantation of internal loop recorders (within the first 100 days) yields the highest diagnostic yield 6.

Current Treatment Approach

  • Patients with cryptogenic stroke/ESUS should be treated with aspirin and aggressive atherosclerosis risk factor management 2
  • Randomized controlled trials have demonstrated no benefit of oral anticoagulants over aspirin in preventing recurrent stroke in unselected cryptogenic stroke patients 2
  • Treatment remains a clinical dilemma in the absence of a confirmed etiology, emphasizing the importance of thorough investigation 3

References

Guideline

Diagnostic Work‑Up for Cryptogenic Stroke

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Cryptogenic stroke: definitions and management.

Hematology. American Society of Hematology. Education Program, 2025

Research

Current perspectives on the clinical management of cryptogenic stroke.

Expert review of neurotherapeutics, 2023

Research

[Cryptogenic stroke management : where are we ?].

Annales de cardiologie et d'angeiologie, 2021

Research

Stroke Prevention After Cryptogenic Stroke.

Current cardiology reports, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.